All Stories

Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset

Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles River Laboratories to help test the asset in a preclinical model of the autoimmune disease.

Feb 13, 2025 - 21:19
 0
Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset
Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles River Laboratories to help test the asset in a preclinical model of the autoimmune disease.
Read More

Tags:

Previous Article

IHG and Pacini Group Join Forces to Bring Garner Hotel Brand to Italy

Next Article

Own A Unique Piece Of Cinematic History: Yi Zhou’s New Artworks Include Archival...

Related Posts

Cash-strapped Vincerx left mulling future after Oqory reverse merger falls apart

Cash-strapped Vincerx left mulling future after Oqory r...

Mar 3, 2025  0

2 NIH leaders depart as White House cuts thousands of jobs across federal health agencies

2 NIH leaders depart as White House cuts thousands of j...

Feb 18, 2025  0

J&J’s Shockwave Medical launches path-clearing Javelin lithotripsy catheter

J&J’s Shockwave Medical launches path-clearing Javelin ...

Mar 5, 2025  0